Feb 10, 2017 - by Niamh Marriott of European Pharmaceutical Review
The technology is astounding and has the potential to revolutionise the healthcare industry, give better treatment and diagnosis to patients, ensure productivity and communication within medical facilities and can provide personalised, targeted medicine. But what about the dangers, the privacy and security of information, and the risks to personal patient data? Do the benefits outweigh the risks? With IoT establishing itself in modern life, is IoMT the future of healthcare? We caught up with Nexeon’s CEO Will Rosellini to find out more…
Jan 24, 2017 - by Nick Ismail of Information Age
As smart devices connected by the Internet of Things become an increasing presence in homes and on the streets, the next stage is moving this technology to the healthcare system. In 2013, President Obama launched the BRAIN Initiative as a large-scale effort to equip researchers with insights necessary for treating a wide variety of brain disorders like Alzheimer’s, schizophrenia, autism, epilepsy, and traumatic brain injury. The World Health Organization estimates that devastating brain disorders affect more than one billion people worldwide.
Jan 23, 2017 - by Olivia Nguyen of DMagazine
"The Form 10 process has two immediate benefits," said Chairman and CEO Will Rosellini. "One, the financial transparency inherent in being a fully-reporting company will reveal our ongoing commitment to running lean operations and optimizing for our shareholder's return on equity. And secondly... I'm confident that a slow approach to a registered public offering offers a better opportunity for our existing and new shareholders."
Nov 11, 2016
“Nexeon is developing a new future for patients who suffer from neurological diseases,” said William Rosellini, Nexeon Chairman and CEO. “Preclinical research is difficult to translate to humans, but support from the NIH helps us understand the disorders, improve the technology, and expand the clinical indications so that one day, a patient with a neurological disease can be restored to a normal state.”